ArticleCell biology and toxicology2026
GPNMB regulates EGFR mitochondrial translocation via HK2, influencing microglial respiratory chain and metabolic defects to promote polarization and stroke progression.
Article in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOne of the main reasons of disability and death is stroke in China and other countries, with growing evidence pointing to the role of microglial polarization in its pathogenesis. Epidermal growth factor receptor as well as Glycoprotein non-metastatic melanoma protein have been implicated in cellular signaling pathways relevant to microglial function. However, the mechanism by which GPNMB regulates EGFR signaling and its impact on mitochondrial translocation and polarization remains unclear.
methodsWe established middle cerebral artery occlusion model in mice to investigate GPNMB expression and its role in microglial activation. Various experimental techniques, including TTC staining, western blotting, Nissl staining, H&E staining, immunofluorescence, and flow cytometry, were employed to assess cellular changes and molecular interactions. Furthermore, the effects of GPNMB on energy metabolism were evaluated through ATP assays and mitochondrial membrane potential assessments.
resultsUpregulated GPNMB was observed in microglia following MCAO. GPNMB Inhibition resulted in reduced infarct volume, diminished neuronal damage, and altered microglial polarization towards the anti-inflammation phenotype. Additionally, GPNMB was found to regulate EGFR translocation, which in turn influenced HK2 expression, thereby affecting mitochondrial function and energy metabolism in microglia. Expression of respiratory-chain proteins (CYTB, MTCO2, ATP6) was increased following GPNMB inhibition. The use of EGFR activators and inhibitors further confirmed the critical role of this signaling pathway in mediating GPNMB's effects.
conclusionIn conclusion, GPNMB regulates mitochondrial translocation of ERGR via HK2, influencing microglial respiratory chain and metabolic defects to promote stroke progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.